ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Doesn't Plan To Extend Bid For Illumina

DOW JONES NEWSWIRES Roche Holding AG (ROG.VX) said it doesn't plan to extend its unsolicited takeover bid worth more than $6.5 billion for Illumina Inc. (ILMN) past Friday's deadline, citing preliminary estimates indicating that the incumbents on the U.S. gene-sequencing company's will be re-elected. "We do not believe that a price above Roche's offer for Illumina of $51 per share would be in the interest of Roche's shareholders," Roche Chief Executive Severin Schwan said. Ilumina shares were down 9% at $40 in recent premarket trading. Through Wednesday's close the stock was up 44% this year amid the takeover offer. A Roche unit had proposed amending Illumina's bylaws to increase the number of directors on its board and offered two individuals to fill the new slots. If all Roche's proposals were adopted and its nominees elected, Roche's nominees would have constituted a majority of Illumina's board. Three proxy advisory firms had recommended that Illumina's shareholders vote against Roche's slate, and Illumina's board has recommended shareholders reject the proposals. Roche recently raised its offer for Illumina, but the company has continued to spurn the offer as undervaluing its "extraordinary" growth prospects. Roche has called its bid "full, fair and extremely attractive." The world's largest maker of cancer drugs had launched the hostile takeover attempt in late January in part of a search for ways to expand its offerings in the burgeoning personalized-medicine market. -By Tess Stynes and Joan E. Solsman, Dow Jones Newswires; 212-416-2481;

Stock News for Illumina (ILMN)
11/19/201515:03:03Why Pacific Biosciences of California Is Soaring Higher Today
11/16/201517:18:21Statement of Changes in Beneficial Ownership (4)
11/12/201518:44:00Illumina Set to Join the S&P 500
11/12/201509:18:03Why Pacific Biosciences of California Jumped 30% in October
11/04/201517:45:28Statement of Changes in Beneficial Ownership (4)
11/02/201516:32:01Quarterly Report (10-q)
11/02/201506:30:00Illumina Announces New $250 Million Share Repurchase Authorization
11/01/201515:20:03Qiagen NV Earnings: Just What You'd Expect
10/27/201515:14:42Why Pacific Biosciences of California Went Up, Then Down, Then...
10/25/201513:40:06Is Profitiablity in Pacific Biosciences of California's DNA?
10/25/201510:01:06Illumina Inc. Reports Disappointing Q3 Sales
10/23/201512:54:46Why Pacific Biosciences of California Jumped Today
10/21/201500:27:03Illumina (ILMN) Jay T. Flatley on Q3 2015 Results - Earnings...
10/20/201516:55:00Illumina (ILMN) Q3 2015 Results - Earnings Call Webcast
10/20/201516:25:27Ilumina Q3 top line up 15%; EPS up 25%; CF Ops up 24%; earnings...
10/20/201516:08:30Illumina beats by $0.01, misses on revenue
10/20/201516:05:00Illumina Reports Financial Results for Third Quarter of Fiscal...
10/10/201509:54:49Trouble Just Beginning For Illumina
10/07/201519:47:18Statement of Changes in Beneficial Ownership (4)
10/07/201506:30:00Illumina Introduces Genomics Solutions to Advance Clinical Research

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations